drugset / Trial / NCT05013320

Combined Dexmedetomidine and Glycopyrrolate Therapy

NCT05013320

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Catheter-related bladder discomfort after transurethral resection of bladder tumor is frequent because of indwelling urinary catheter for irrigation. The mechanism of the catheter-related bladder discomfort is similar to that of overactive bladder, in which muscarinic acetylcholine receptors are stimulated. The catheter-related bladder discomfort is a well known predisposing factor for emergence delirium after general anesthesia. In this study, we aimed to compare the incidence of catheter-related bladder discomfort between dexmedetomidine only therapy and combind dexmedetomidine and glycopyrrolate therapy.

Timeline

Start
2021-09-01
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate Small molecule Intravenous
Comparator Dexmedetomidine Other / unclassified